Sanofi, Regeneron Win Temporary Reprieve in Patent-Infringement Battle with Amgen
By
The United States Court of Appeals for the Federal Circuit has stayed a permanent injunction for Sanofi’s and Regeneron Pharmaceuticals’ Praluent (alirocumab), an anti-cholesterol drug, a proprotein convertase subtilisin/kexin type 9…
KBI Acquires Cell Therapy Manufacturing Plant
By
KBI Biopharma, a Durham, North Carolina-headquartered biopharmaceutical contract development and manufacturing organization, has acquired the manufacturing and laboratory assets of Opexa Therapeutics, a biotechnology company based in The Woodlands, Texas, which…